Oligonucleotide Therapeutics Market, By Oligonucleotide Class (Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA / RNAi), microRNA (miRNA), Aptamers, CpG Oligonucleotides, Ribozymes and Others), By Application, By Delivery System, By End User, By Route of Administration, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

TABLE OF CONTENTS
1. Oligonucleotide Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Oligonucleotide Therapeutics Key Market Trends
3.1. Oligonucleotide Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Oligonucleotide Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Oligonucleotide Therapeutics Market Opportunities
3.4. Oligonucleotide Therapeutics Market Future Trends
4. Oligonucleotide Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Oligonucleotide Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Oligonucleotide Therapeutics Market Landscape
6.1. Oligonucleotide Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Oligonucleotide Therapeutics Market – By Oligonucleotide Class
7.1. Overview
7.1.1. Segment Share Analysis, By Oligonucleotide Class, 2025 & 2033 (%)
7.1.2. Antisense Oligonucleotides (ASOs)
7.1.3. Small Interfering RNA (siRNA / RNAi)
7.1.4. microRNA (miRNA)
7.1.5. Aptamers
7.1.6. CpG Oligonucleotides
7.1.7. Ribozymes
7.1.8. Others
8. Oligonucleotide Therapeutics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Neurological Disorders
8.1.3. Cardiometabolic Disorders
8.1.4. Oncology
8.1.5. Infectious Diseases
8.1.6. Kidney / Renal Diseases
8.1.7. Ophthalmology
8.1.8. Others
9. Oligonucleotide Therapeutics Market – By Delivery System
9.1. Overview
9.1.1. Segment Share Analysis, By Delivery System, 2025 & 2033 (%)
9.1.2. Lipid Nanoparticles (LNPs)
9.1.3. GalNAc Conjugates
9.1.4. Peptide Conjugates
9.1.5. Polymer-Based Delivery Systems
9.1.6. Other Conjugates / Delivery Systems
10. Oligonucleotide Therapeutics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Pharmaceutical & Biotechnology Companies
10.1.3. Hospitals & Specialty Clinics
10.1.4. Academic & Research Institutes
10.1.5. Contract Research Organizations (CROs)
10.1.6. Others
11. Oligonucleotide Therapeutics Market – By Route of Administration
11.1. Overview
11.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
11.1.2. Subcutaneous
11.1.3. Intravenous
11.1.4. Intrathecal
11.1.5. Intramuscular
11.1.6. Others
12. Oligonucleotide Therapeutics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Oligonucleotide Therapeutics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Oligonucleotide Therapeutics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.18. Denmark
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Denmark Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Denmark Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.18.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18.7. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.3.19. Rest of Europe
12.3.19.1. Overview
12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.19.3. Rest of the Europe Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.19.5. Rest of the Europe Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.3.19.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.19.7. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Oligonucleotide Therapeutics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.17. Taiwan
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Taiwan Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Taiwan Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.17.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17.7. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.18. Vietnam
12.4.18.1. Overview
12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.18.3. Vietnam Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.18.5. Vietnam Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.18.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.18.7. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.4.19. Rest of APAC
12.4.19.1. Overview
12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.19.3. Rest of APAC Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.19.5. Rest of APAC Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.4.19.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.19.7. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Oligonucleotide Therapeutics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Oligonucleotide Therapeutics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.15. Iran
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Iran Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Iran Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.15.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15.7. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.16. Qatar
12.6.16.1. Overview
12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.16.3. Qatar Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.16.5. Qatar Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.16.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.16.7. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
12.6.17. Rest of MEA
12.6.17.1. Overview
12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.17.3. Rest of MEA Market Size and Forecast, By Oligonucleotide Class, 2020 - 2033 (US$ Million)
12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.17.5. Rest of MEA Market Size and Forecast, By Delivery System, 2020 - 2033 (US$ Million)
12.6.17.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.17.7. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Oligonucleotide Therapeutics Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Ionis Pharmaceuticals, Inc.
13.2.2. Alnylam Pharmaceuticals, Inc.
13.2.3. Sarepta Therapeutics, Inc.
13.2.4. Biogen Inc.
13.2.5. Novartis AG
13.2.6. Arrowhead Pharmaceuticals, Inc.
13.2.7. Roche / Genentech
13.2.8. Astellas Pharma Inc.
13.2.9. Nippon Shinyaku Co., Ltd.
13.2.10. Amgen Inc.
13.2.11. Regeneron Pharmaceuticals, Inc.
13.2.12. BioMarin Pharmaceutical Inc.
13.2.13. Moderna, Inc.
13.2.14. Wave Life Sciences Ltd.
13.2.15. Arcturus Therapeutics Holdings Inc.
13.2.16. Avidity Biosciences, Inc.
13.2.17. Silence Therapeutics plc
13.2.18. Nitto Denko Corporation / Nitto Denko Avecia
13.2.19. Stoke Therapeutics, Inc.
13.2.20. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Ionis Pharmaceuticals, Inc.
• Alnylam Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Biogen Inc.
• Novartis AG
• Arrowhead Pharmaceuticals, Inc.
• Roche / Genentech
• Astellas Pharma Inc.
• Nippon Shinyaku Co., Ltd.
• Amgen Inc.
• Regeneron Pharmaceuticals, Inc.
• BioMarin Pharmaceutical Inc.
• Moderna, Inc.
• Wave Life Sciences Ltd.
• Arcturus Therapeutics Holdings Inc.
• Avidity Biosciences, Inc.
• Silence Therapeutics plc
• Nitto Denko Corporation / Nitto Denko Avecia
• Stoke Therapeutics, Inc.
• Others

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY OLIGONUCLEOTIDE CLASS- MARKET ANALYSIS, 2020 - 2033

• Antisense Oligonucleotides (ASOs)
• Small Interfering RNA (siRNA / RNAi)
• microRNA (miRNA)
• Aptamers
• CpG Oligonucleotides
• Ribozymes
• Others

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

• Neurological Disorders
• Cardiometabolic Disorders
• Oncology
• Infectious Diseases
• Kidney / Renal Diseases
• Ophthalmology
• Others

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY DELIVERY SYSTEM- MARKET ANALYSIS, 2020 - 2033

• Lipid Nanoparticles (LNPs)
• GalNAc Conjugates
• Peptide Conjugates
• Polymer-Based Delivery Systems
• Other Conjugates / Delivery Systems

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

• Pharmaceutical & Biotechnology Companies
• Hospitals & Specialty Clinics
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

• Subcutaneous
• Intravenous
• Intrathecal
• Intramuscular
• Others

GLOBAL OLIGONUCLEOTIDE THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

The Middle East and Africa

• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA